Home LiteratureArticle Details
PMID: 18363506 Published · ppublish English Journal Article Review

Expression strategies for short hairpin RNA interference triggers.

Human gene therapy ·Vol. 19 ·No. 4 ·2008-04-00 ·Pages 313-7

Rossi JJ

Abstract

Since the discovery that the triggers for RNA interference (RNAi), small interfering RNAs, could mediate silencing in mammalian cells without triggering a toxic response, RNAi has become the standard tool for sequence-specific knockdown of gene expression in molecular biology. This is due in part to the development of methods for promoter-based expression of RNAi triggers that can mediate stable silencing in mammalian cells. Numerous systems with slightly different characteristics exist, but despite incredible progress in a field that moves very rapidly, challenges still remain. The biggest challenge is to successfully and safely apply RNAi in vivo. Aside from potential issues of delivery, which is one of the most important considerations, successful application of short hairpin RNAs (shRNAs) in vivo requires expression systems that yield potent and specific knockdown of the target in the absence of toxicity. With a couple of exceptions, the current systems available for shRNA expression have not generally resulted in unexpected toxicities, while still providing strong knockdown of the intended targets; however, we do not know enough about how sequence-specific off-target effects will affect various cell and tissue types, or to what extent ectopic expression of RNAi triggers will perturb the endogenous RNAi mechanisms.

MeSH Terms
Animals RNA/chemistry,genetics,metabolism RNA Interference RNA, Small Interfering/genetics,metabolism
Chemicals
RNA, Small Interfering RNA
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Rossi John J
Division of Molecular Biology, Beckman Research Institute of the City of Hope, Graduate School of Biological Sciences, Duarte, CA 91010, USA. jrossi@bricoh.edu
References (54)
54 references, click to expand
  1. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells.
    Mol Cell. 2002 Jun;9(6):1327-33 PMID: 12086629
  2. Unlocking the potential of the human genome with RNA interference.
    Nature. 2004 Sep 16;431(7006):371-8 PMID: 15372045
  3. Inducible shRNA expression for application in a prostate cancer mouse model.
    Nucleic Acids Res. 2003 Nov 1;31(21):e127 PMID: 14576327
  4. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.
    Nat Biotechnol. 2002 May;20(5):500-5 PMID: 11981565
  5. Progress and prospects: the design and production of plasmid vectors.
    Gene Ther. 2009 Feb;16(2):165-71 PMID: 19129858
  6. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity.
    RNA. 2006 Jul;12(7):1179-87 PMID: 16682560
  7. Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro.
    Nat Biotechnol. 2006 May;24(5):566-71 PMID: 16648841
  8. Dicer is essential for mouse development.
    Nat Genet. 2003 Nov;35(3):215-7 PMID: 14528307
  9. Approaches for chemically synthesized siRNA and vector-mediated RNAi.
    FEBS Lett. 2005 Oct 31;579(26):5974-81 PMID: 16199038
  10. The inhibitory efficacy of RNA POL III-expressed long hairpin RNAs targeted to untranslated regions of the HIV-1 5' long terminal repeat.
    Oligonucleotides. 2007 Winter;17(4):419-31 PMID: 17896874
  11. A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro.
    Transfusion. 2009 May;49(5):967-76 PMID: 19175544
  12. Distance constraints between microRNA target sites dictate efficacy and cooperativity.
    Nucleic Acids Res. 2007;35(7):2333-42 PMID: 17389647
  13. RNA interference is mediated by 21- and 22-nucleotide RNAs.
    Genes Dev. 2001 Jan 15;15(2):188-200 PMID: 11157775
  14. Rapid assessment of anti-HIV siRNA efficacy using PCR-derived Pol III shRNA cassettes.
    Mol Ther. 2004 Sep;10(3):597-603 PMID: 15336659
  15. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Hum Gene Ther. 2009 Jul;20(7):739-50 PMID: 19278303
  16. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.
    Mol Ther. 2003 Jul;8(1):62-71 PMID: 12842429
  17. Gene silencing using micro-RNA designed hairpins.
    RNA. 2002 Jun;8(6):842-50 PMID: 12088155
  18. Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA.
    Nat Biotechnol. 2004 Dec;22(12):1573-8 PMID: 15568018
  19. An extensive class of small RNAs in Caenorhabditis elegans.
    Science. 2001 Oct 26;294(5543):862-4 PMID: 11679672
  20. Functional siRNA expression from transfected PCR products.
    RNA. 2002 Nov;8(11):1454-60 PMID: 12458798
  21. Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs.
    RNA. 2005 Feb;11(2):220-6 PMID: 15613540
  22. Expression profiling reveals off-target gene regulation by RNAi.
    Nat Biotechnol. 2003 Jun;21(6):635-7 PMID: 12754523
  23. RNA interference in mice.
    Handb Exp Pharmacol. 2007;(178):149-76 PMID: 17203655
  24. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
    Nature. 2001 May 24;411(6836):494-8 PMID: 11373684
  25. 5'-triphosphate-dependent activation of PKR by RNAs with short stem-loops.
    Science. 2007 Nov 30;318(5855):1455-8 PMID: 18048689
  26. Adeno-associated virus vectors for short hairpin RNA expression.
    Methods Enzymol. 2005;392:381-405 PMID: 15644194
  27. pHUSH: a single vector system for conditional gene expression.
    BMC Biotechnol. 2007 Sep 26;7:61 PMID: 17897455
  28. Interactions between double-stranded RNA regulators and the protein kinase DAI.
    Mol Cell Biol. 1992 Nov;12(11):5238-48 PMID: 1357546
  29. Determinants of interferon-stimulated gene induction by RNAi vectors.
    Differentiation. 2004 Mar;72(2-3):103-11 PMID: 15066190
  30. Stable suppression of gene expression by RNAi in mammalian cells.
    Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1443-8 PMID: 11818553
  31. Inducible H1 promoter-driven lentiviral siRNA expression by Stuffer reporter deletion.
    Oligonucleotides. 2005 Summer;15(2):139-44 PMID: 15989428
  32. RNA interference in adult mice.
    Nature. 2002 Jul 4;418(6893):38-9 PMID: 12097900
  33. Induction of an interferon response by RNAi vectors in mammalian cells.
    Nat Genet. 2003 Jul;34(3):263-4 PMID: 12796781
  34. Effective expression of small interfering RNA in human cells.
    Nat Biotechnol. 2002 May;20(5):505-8 PMID: 11981566
  35. MicroRNA genes are transcribed by RNA polymerase II.
    EMBO J. 2004 Oct 13;23(20):4051-60 PMID: 15372072
  36. Approaches for the sequence-specific knockdown of mRNA.
    Nat Biotechnol. 2003 Dec;21(12):1457-65 PMID: 14647331
  37. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells.
    Mol Ther. 2004 Jul;10(1):191-9 PMID: 15272480
  38. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Mol Ther. 2007 May;15(5):938-45 PMID: 17311008
  39. Expression of long anti-HIV-1 hairpin RNAs for the generation of multiple siRNAs: advantages and limitations.
    Mol Ther. 2008 Jan;16(1):170-7 PMID: 17726454
  40. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.
    Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6047-52 PMID: 11972060
  41. New microRNAs from mouse and human.
    RNA. 2003 Feb;9(2):175-9 PMID: 12554859
  42. Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.
    Mol Ther. 2007 Jun;15(6):1182-8 PMID: 17406343
  43. Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis.
    J Virol. 2004 Dec;78(23):12868-76 PMID: 15542639
  44. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
    Mol Ther. 2005 Nov;12(5):900-9 PMID: 16115802
  45. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC.
    Nucleic Acids Res. 2007;35(15):5154-64 PMID: 17660190
  46. Optimization and characterization of tRNA-shRNA expression constructs.
    Nucleic Acids Res. 2007;35(8):2620-8 PMID: 17426139
  47. Inhibition of hepatitis B virus in mice by RNA interference.
    Nat Biotechnol. 2003 Jun;21(6):639-44 PMID: 12740585
  48. 5'-Triphosphate RNA is the ligand for RIG-I.
    Science. 2006 Nov 10;314(5801):994-7 PMID: 17038590
  49. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.
    Mol Ther. 2006 Oct;14(4):494-504 PMID: 16844419
  50. An enhanced U6 promoter for synthesis of short hairpin RNA.
    Nucleic Acids Res. 2003 Sep 1;31(17):e100 PMID: 12930974
  51. Noise amidst the silence: off-target effects of siRNAs?
    Trends Genet. 2004 Nov;20(11):521-4 PMID: 15475108
  52. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.
    Nature. 2006 May 25;441(7092):537-41 PMID: 16724069
  53. Inducible, reversible, and stable RNA interference in mammalian cells.
    Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1927-32 PMID: 14762164
  54. A microRNA in a multiple-turnover RNAi enzyme complex.
    Science. 2002 Sep 20;297(5589):2056-60 PMID: 12154197
Article Info
Journal
Human gene therapy
Abbr.
Hum Gene Ther
ISSN
1043-0342
Published
2008-04-00
Pages
313-7
Language
English
Region
United States
NLM ID
9008950
PMCID
PMC2702704
Subset
IM
Grants
NIAID NIH HHS · R01 AI042552 · United States
NIAID NIH HHS · R01 AI042552-11 · United States
NIAID NIH HHS · R37 AI029329 · United States
NIAID NIH HHS · R37 AI029329-20 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com